Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,100,000
in 1 filing

Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brennan David R −$3.1M Director sold 39% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-03 Schaeffer Orlov S Nicole Chief People Strategy Officer Sale 10b5-1 −55,000 $55.33 $3.0M 108,760
2024-06-03 Schaeffer Orlov S Nicole Chief People Strategy Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −13,750 0
2024-06-03 Schaeffer Orlov S Nicole Chief People Strategy Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −41,250 0
2024-05-30 Flammer Martina M.D. Chief Medical Officer Exercise or conversion 10b5-1 +21,195 $23.75 $503K 127,329
2024-05-30 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −21,195 $55.00 $1.2M 106,134
2024-05-30 Flammer Martina M.D. Chief Medical Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −21,195 35,325
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +76,731 $28.88 $2.2M 197,666
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +27,074 $24.70 $669K 228,194
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +25,046 $34.03 $852K 256,694
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +39,446 $26.46 $1.0M 299,594
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +20,111 $26.43 $532K 323,159
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion 10b5-1 +32,156 $17.07 $549K 358,769
2024-05-29 Bonstein Sara Chief Financial Officer Sale 10b5-1 −220,564 $50.00 $11.0M 117,481
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −76,731 11,455
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −27,074 4,362
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −25,046 17,100
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −39,446 25,740
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −20,111 39,275
2024-05-29 Bonstein Sara Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −32,156 59,350
2024-05-28 Wise John Drayton Chief Commercial Officer Sale 10b5-1 −1,602 $48.95 $78K 121,657

Page 38 of 42 · 826 trades